Related Experiment Video
Updated: Jun 22, 2025

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?
João Pessoa1, Sandrina Nóbrega-Pereira1, Bruno Bernardes de Jesus1
1Department of Medical Sciences and Institute of Biomedicine - iBiMED, University of Aveiro, Aveiro 3810-193, Portugal.
Abstract:
Two recent seminal works have untangled the intricate role of tumor-associated senescent cells in cancer progression, or regression, by guiding our immune system against cancer cells. The characterization of these unique, yet diverse cell populations, should be considered, particularly when contemplating the use of senolytics, which are drugs that selectively eliminate senescent cells, in a cancer framework. Here, we will describe the current knowledge in this field. In particular, we will discuss how the presence of senescent cells in tumors could be used as a therapeutic target in immunogenic cancers and how we may hypothetically design an adaptive anti-aging vaccine.
Insights
Tumor-associated senescent cells can promote or inhibit cancer by influencing the immune system. Understanding these cells is crucial for developing senolytics and potential anti-aging vaccines for cancer therapy.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Tumor-associated senescent cells play a complex role in cancer, influencing both progression and regression.
- Recent research highlights their ability to modulate the host immune system against cancer cells.
Purpose of the Study:
- To review current knowledge on tumor-associated senescent cells in cancer.
- To discuss senescent cells as a therapeutic target in cancer treatment.
- To explore the potential for designing adaptive anti-aging vaccines.
Main Methods:
- Literature review of recent seminal works.
- Analysis of the role of senescent cells in cancer immunity.
- Conceptualization of senolytic therapies and vaccine strategies.
Main Results:
- Senescent cells exhibit diverse characteristics within tumors.
- Their presence can be leveraged as a therapeutic target in immunogenic cancers.
- Senolytics, drugs eliminating senescent cells, require careful consideration in cancer treatment.
Conclusions:
- Targeting senescent cells offers a promising avenue for cancer immunotherapy.
- Further research into senescent cell populations is vital for optimizing senolytic drug efficacy.
- Adaptive anti-aging vaccines represent a novel hypothetical approach for cancer prevention and treatment.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Replicative Cell Senescence
Tumor Immunotherapy
Vaccinations
Telomeres and Telomerase
Cells of the Adaptive Immune Response

